Abstract
Currently, pancreatic cancer is an invasive cancer that is difficult to treat, and the success of clinical trials against cancer remains low. Pancreatic ductal adenocarcinoma is the most common, and the 5-year survival rate is less than 10%. Traditional in vitro tumor models do not replicate the complexity of the tumor microenvironment and response to therapies, so this project aims to de…